Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sabri

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Nuklearmedizin. Nuclear Medicine|June 1, 1994
A method of correlating and merging cerebral morphology and function by a special head holderH J Kaiser, O Sabri, G Wagenknecht, et al.
Nuklearmedizin. Nuclear Medicine|April 18, 2000
[Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose]K Setani, M Schreckenberger, O Sabri, et al.
European Journal of Neurology|October 25, 2007
Eye of the tiger sign in multiple system atrophyK Strecker, S Hesse, F Wegner, et al.
Journal of Neurology|July 20, 2004
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxiaP Günther, A Storch, J Schwarz, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Radioiodine therapy in veterinary medicine: treatment of hyperthyroidism in a cat]P Reinartz, O Sabri, S Kinzel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2006
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndromeS Hesse, C Oehlwein, H Barthel, et al.
Clinical Nuclear Medicine|September 13, 2000
High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case reportP T Meyer, U Spetzger, H D Mueller, et al.
Nuklearmedizin. Nuclear Medicine|December 22, 1999
[Role of positron emission tomography (PET) and single photon emission tomography (SPECT) in so-called "multiple chemical sensitivity"]P Bartenstein, F Grünwald, K Herholz, et al.
Zeitschrift Fur Gastroenterologie|May 5, 2005
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]D Müller, M Wiedmann, R Kluge, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medicationO Sabri, M Zimny, G Schulz, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Nuklearmedizin. Nuclear Medicine|June 1, 1994
A method of correlating and merging cerebral morphology and function by a special head holderH J Kaiser, O Sabri, G Wagenknecht, et al.
Nuklearmedizin. Nuclear Medicine|April 18, 2000
[Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose]K Setani, M Schreckenberger, O Sabri, et al.
European Journal of Neurology|October 25, 2007
Eye of the tiger sign in multiple system atrophyK Strecker, S Hesse, F Wegner, et al.
Journal of Neurology|July 20, 2004
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxiaP Günther, A Storch, J Schwarz, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Radioiodine therapy in veterinary medicine: treatment of hyperthyroidism in a cat]P Reinartz, O Sabri, S Kinzel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2006
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndromeS Hesse, C Oehlwein, H Barthel, et al.
Clinical Nuclear Medicine|September 13, 2000
High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case reportP T Meyer, U Spetzger, H D Mueller, et al.
Nuklearmedizin. Nuclear Medicine|December 22, 1999
[Role of positron emission tomography (PET) and single photon emission tomography (SPECT) in so-called "multiple chemical sensitivity"]P Bartenstein, F Grünwald, K Herholz, et al.
Zeitschrift Fur Gastroenterologie|May 5, 2005
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]D Müller, M Wiedmann, R Kluge, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medicationO Sabri, M Zimny, G Schulz, et al.
Pageof 12